Company intelligence / Profile preview
Tritech Biopharmaceuticals Co., Ltd.
- Ownership
- Private
- Development stage
- Preclinical
Overview
Tritech has developed a topical vardenafil gel (TR399) for erectile dysfunction that has completed a phase I/IIa trial with favorable results—side effect free, low Cmax, and long-lasting efficacy. Other pipeline programs are in preclinical or IND stages targeting pulmonary arterial hypertension, osteoporosis, insomnia, Raynaud syndrome, and hemangioma. The company specializes in non-invasive drug delivery using its proprietary screening platform to optimize transdermal formulations with improved safety profiles.[1][2][3][6]
- Therapeutic areas
- CardiovascularMen's HealthEndocrinologyRare DiseasesNeurology
- Modalities
- Small moleculesChemical drugsTopical/transdermal formulations[1][3][6]
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Tritech Biopharmaceuticals Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tritech Biopharmaceuticals Co., Ltd..